Cytogenetic/translocations Flashcards
BCR gene
chromosome 22
ABL gene
chromosome 9
BCR-ABL fusion gene
Chronic Myelogenous Leukemia (CML)
activating point mutations
in JAK/2 TYROSINE
KINASE
P. vera
Essential thrombocytosis
Primary
myelofibrosis
Polycythemia vera Cytogenetic
activating point mutations
in JAK/2 TYROSINE
KINASE
MPL mutation–> thrombopoietin activated
protein kinase
Essential
thrombocytosis;
Primary
myelofibrosis
Calreticulin mutation
Essential thrombocytosis;
functions
in the
endoplasmic reticulum
Calreticulin mutation
Inappropriate release of
fibrogenic factors from
neoplastic megakaryocytes
PDGF and TGF-beta
Primary
myelofibrosis
BCR-ABL fusion protein induces signaling via
RAS and JACK/STAT pathways
CML
Negative Leukocyte alkaline phosphatase (LAP)
CML
Positive LAP
leukemoid rxn
can transfrom to AML or ALL
CML
loss of function mutations in Pax5,
TEL/AML translocation
and E2A
B cell ALL
NOTCH gain of function
mutation
T cell ALL
B-cell have Ig light chain and CD19, 20, 22, 103 and annexin but NOT CD21
Hairy Cell Leukemia
express CD45 and Tartrate resistant acid phosphatase (TRAP).
Hairy Cell Leukemia
t(15,17)
Acute promyelocytic
leukemia (M3)
PML/RARalpha in-frame fusion of gene coding sequences which results in a functional unregulated retinoic acid receptor
Acute promyelocytic
leukemia (M3)
Activating point mutations in serine/threonine kinase BRAF downstream from RAS in the MAPK cascade.
Hairy Cell Leukemia
up regulation of the antiapoptotic
protein BCL-2
CLL/
SLL
trisomy
12 or deletions of 11, 13, or
17.
CLL/
SLL
Bcl-2
Normally antiapoptotic; when UPREGULATED, then no apoptosis–> cancer
CD19, CD20 and coexpress CD5 (T-cell marker)
CLL/SLL;
Mantle cell
lymphoma
slow, indolent
course; can
transform to DLBCL
(Richter’s syndrome
CLL/SLL;
Absolute lymphocytosis on peripheral blood smear:
•
W/ small lymphocytes, smudge cells, AIHA (spherocytes)
CLL/SLL;
large, rapidly expanding abdominal mass—higher grade type lymphoma)
CLL Transformation to DLBCL or Richters Syndrome
overexpression of cycle D1 that promotes G1 to S-phase progression.
Mantle Cell Lymphoma
Cyclin D1 chromosome
11
IgH chromosome
14
t(11, 14)
Mantle Cell Lymphoma
t(14:18)
Follicular lymphoma
BCL gene chromosome
18
over expression of BCL2
protein and therefore
increased cell survival
Follicular lymphoma
(14:18) chromosomal translocation; fusion of the BCL gene on chromosome 18 with the IgH locus on chromosome 14
Follicular lymphoma
mutations of BCL6 which is involved in normal germinal B-cell maturation and growth arrest and apoptosis; (14:18) translocation; MYC translocations;
Diffuse Large B-cell
lymphoma
MYC gene chromosome
chromosome 8
(8:14) translocation
Burkitt lymphoma
translocations of the MYC
gene on chromosome 8
mostly with the IgH gene
on chromosome 14
Burkitt lymphoma
Overexpression of BCL-6
DLBCL
rapidly enlarging mass at nodal or commonly extra nodal sites almost anywhere in the body (skin, bone, brain and GI tract, tonsils, liver and spleen)
DLBCL
constitutional symptoms of fever, night sweats, weight loss
B symptoms in Hodgkins
Strongly associated w/ EBV
Hodgkins
activation of NF-kappaB transcription factor
Hodgkins
large B cells with
multilobcd nuclei and prominent nucleoli
Reed Sternberg cells
activation of NF-kappaB transcription factor–> result?
↑lymphocyte survival and proliferation
a variant of the Reed‐Sternberg cell which shows a large clear space surrounding the nucleus
lacunar cell; refers to nodular sclerosis
The lacunar cells express (1)
CD15, CD30 and PAX5 a pan B‐cell marker; nodular sclerosis
mass in the
cervical, supraclavicular or
commonly the mediastinal area in
young adolescents
Nodular sclerosis
shows characteristic nodules surrounded by bands of collagenous tissue and containing mixtures of lymphoid cells, inflammatory cells and lacunar cells
nodular sclerosis
Hodkgins:
older patients and in HIV+ patients of any age
Lymphocyte depleted
Hodkgins:
best prognosis
nodular sclerosis
Translocation IgG locus
chromosome 14 fusion
partner fibroblast growth
factor 3 on chromosome 4
Multiple
myeloma
Chromosomal
translocations IgH locus on
chromosome 14 and PAX5
gene on chromosome 9
Lymphoplasmacytic
Lymphoma
Reed sternberg cells cytology
CD15+ CD30+ CD20-
bilobed nucleus with prominent nucleolus with surrounding clear space
RS cell
hodgkins lymphoma (4 types) vs. lymphocyte predominant HL cytology
Hodgkins–> CD15+ CD30+ CD20- PAX5
lymphocyte pred–> CD20+ BCL6;
lymphocyte predominant histo hallmark
popcorn cell
nodular sclerosis histo hallmark
bands of collagen bet. the lymph node nodules;
mixed cellularity histo hallmark
lymphocytes, EOSINOPHILS, many RS cells
increased susceptibility to infection
multiple myeloma
bone pain
fractures;
HYPERCALCEMIA
thrombocytopenia
multiple myeloma
CRAB pneumonic for multiple myeloma
hyperCalcemia
Renal involvement (Bence Jones proteinuria)
Anemia
Bone lytic lesion
trisomy 8.
myelodysplastic syndrome
RPS14 Ribosomal protein on the lost portion of 5q—which when lost, promotes dysmaturation.
myelodysplastic syndrome
myelodysplastic syndrome–>often with good prognosis
5q
myelodysplastic syndrome–> poor prognosis
7q
Giant platelets
Peripheral blood myelodysplastic syndrome
Monosomy of 5 and 7
Deletions 5q ,7q,
trisomy 8.
myelodysplastic syndrome
Retrovirus-caused (HTLV-1) tumor of CD4+ T-cells;
Adult T-cell Lymphoma/Leukemia
Caused by HTLV-1—especially affects populations in southern Japan, Caribbean, West Africa
Adult T-cell Lymphoma/Leukemia
Cutaneous lesions
Marked hypercalcemia
Adult T-cell Lymphoma/Leukemia
Circulating tumor cells w/ CD25+ (IL-2 receptor)
Adult T-cell Lymphoma/Leukemia
CD19, 20, 23 and 5
CLL/SLL